Accelerating Medicines Partnership Archives - Lupus Research Alliance

Tag: Accelerating Medicines Partnership

Promising Results from AMP

The Lupus Research Alliance is one of the sponsors of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus), a public-private partnership between the National Institutes of Health, the U.S. Food and Drug Administration and several pharmaceutical companies and nonprofit organizations. . AMP aims to speed the development of new therapies, and we […] Read More

Advancing Research Exponentially

August 14, 2018 Advancing Research Exponentially An Update on AMP by Jill Buyon, MD Lupus nephritis (LN), one of the dreaded complications of lupus, causes patients to suffer, sometimes for decades, with no new treatment in sight. But now is the time to leverage technology for major advances, which is exactly what the Accelerating Medicines […] Read More

Lupus Research Alliance Investment in Innovation Delivers Results

June 27, 2018 This new issue of the Lupus Research Update (LRU) takes you behind the scenes of some of the most groundbreaking research and how the Lupus Research Alliance raises the funds that enable diverse and accomplished scientists to pioneer new studies in the field. Featured in this LRU, Penn State researcher Dr. Laura […] Read More

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

February 21, 2018 Source: Press Release, National Institutes of Health NIH program to accelerate therapies for arthritis, lupus releases first datasets Collaborative effort provides important clues about potential research targets NEW YORK, NY. Feb. 21, 2018. Datasets characterizing individual cells in rheumatoid arthritis and systemic lupus erythematosus disease tissue from the Accelerating Medicines Partnership for […] Read More